\-\ Texto\\:\\ \ \(0\)\
\-\ hard\\ mass\\ right\\ temple\\,\\ with\\ proptosis\\ od\ \(0\)\
\-\ pending\ \(213\)\
\-\ \\â\\€\\¢\\ large\\ mass\\ destroying\\ the\\ right\\ orbital\\ rim\\ with\\ extension\\ into\\ orbit\\,\\ middle\\ cranial\\ fossa\\,\\ and\\ infratemporal\\ fossa\ \(0\)\
\-\ \\â\\€\\¢\\ second\\ smaller\\ mass\\ right\\ frontal\\ bone\\.\ \(0\)\
\-\ \\â\\€\\¢\\ both\\ masses\\ enhance\\ homogeneously\\.\ \(0\)\
\-\ breast\\ cancer\\,\\ metastatic\\ to\\ orbit\\ and\\ brain\ \(0\)\
\-\ \\â\\€\\¢\\ thyroid\\ metastatic\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ gi\\ metastatic\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ renal\\ metastatic\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ breast\\ cancer\\ metastatic\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ melanoma\\ metastasis\ \(0\)\
\-\ 57\\ year\\ old\\ woman\\ with\\ a\\ known\\ diagnosis\\ has\\ developed\\ right\\ eye\\ proptosis\\ and\\ pain\ \(1\)\
\-\ this\\ woman\\ was\\ known\\ to\\ have\\ metastatic\\ breast\\ cancer\\,\\ prior\\ to\\ this\\ admission\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ metastatic\\:\\ 0\\.40646788919340016\ \(0\)\
\-\ breast\\:\\ 0\\.26909034855905917\ \(0\)\
\-\ proptosis\\:\\ 0\\.24924299665190675\ \(0\)\
\-\ cancer\\:\\ 0\\.2468195517622163\ \(0\)\
\-\ orbit\\:\\ 0\\.22879519124786538\ \(0\)\
\-\ disease\\:\\ 0\\.20739755982387803\ \(0\)\
\-\ fossa\\:\\ 0\\.1939355034404135\ \(0\)\
\-\ temple\\:\\ 0\\.18875589070610596\ \(0\)\
\-\ destroying\\:\\ 0\\.1825265289876694\ \(0\)\
\-\ infratemporal\\:\\ 0\\.17040881467656327\ \(0\)\
\-\ right\\:\\ 0\\.1638082221562657\ \(0\)\
\-\ known\\:\\ 0\\.159941261790734\ \(0\)\
\-\ od\\:\\ 0\\.14372842887968917\ \(0\)\
\-\ mass\\:\\ 0\\.14154425177250887\ \(0\)\
\-\ homogeneously\\:\\ 0\\.12871927493755025\ \(0\)\
\-\ woman\\:\\ 0\\.12865944329852258\ \(0\)\
\-\ hard\\:\\ 0\\.12215419127002067\ \(0\)\
\-\ 57\\:\\ 0\\.11660156062644411\ \(0\)\
\-\ melanoma\\:\\ 0\\.11534955691831714\ \(0\)\
\-\ smaller\\:\\ 0\\.1111596904901455\ \(0\)\
\-\ enhance\\:\\ 0\\.11056640318698732\ \(0\)\
\-\ orbital\\:\\ 0\\.10834356791577815\ \(0\)\
\-\ gi\\:\\ 0\\.1037595770612083\ \(0\)\
\-\ admission\\:\\ 0\\.10305875110231212\ \(0\)\
\-\ pending\\:\\ 0\\.10159240668430518\ \(0\)\
\-\ cranial\\:\\ 0\\.10095735730077621\ \(0\)\
\-\ eye\\:\\ 0\\.09881404110635737\ \(0\)\
\-\ rim\\:\\ 0\\.09836524510417935\ \(0\)\
\-\ thyroid\\:\\ 0\\.09707210677500189\ \(0\)\
\-\ to\\:\\ 0\\.09263941868591605\ \(0\)\
\-\ second\\:\\ 0\\.0924716053348359\ \(0\)\
\-\ developed\\:\\ 0\\.09164186275010215\ \(0\)\
\-\ metastasis\\:\\ 0\\.09053117663140473\ \(0\)\
\-\ middle\\:\\ 0\\.0883272116288933\ \(0\)\
\-\ extension\\:\\ 0\\.0874376798705262\ \(0\)\
\-\ this\\:\\ 0\\.08488752713791971\ \(0\)\
\-\ masses\\:\\ 0\\.08409018288490748\ \(0\)\
\-\ frontal\\:\\ 0\\.07950090245505625\ \(0\)\
\-\ brain\\:\\ 0\\.07700216362380206\ \(0\)\
\-\ renal\\:\\ 0\\.07691951607323842\ \(0\)\
\-\ and\\:\\ 0\\.0765718084050099\ \(0\)\
\-\ with\\:\\ 0\\.07256039549228102\ \(0\)\
\-\ prior\\:\\ 0\\.06910976634839361\ \(0\)\
\-\ both\\:\\ 0\\.06888092794952738\ \(0\)\
\-\ bone\\:\\ 0\\.06739646850742083\ \(0\)\
\-\ into\\:\\ 0\\.0656612095112929\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0640319938330476\ \(0\)\
\-\ large\\:\\ 0\\.0618897494384813\ \(0\)\
\-\ have\\:\\ 0\\.061705112898062235\ \(0\)\
\-\ has\\:\\ 0\\.05642042619934813\ \(0\)\
\-\ pain\\:\\ 0\\.04420007163304865\ \(0\)\
\-\ was\\:\\ 0\\.04304801101732983\ \(0\)\
\-\ year\\:\\ 0\\.03806649232906396\ \(0\)\
\-\ old\\:\\ 0\\.036557009679230194\ \(0\)\
\-\ the\\:\\ 0\\.024646754703264658\ \(0\)\
